European Journal of Cancer
Volume 39, Issue 17 , Pages 2521-2530 , November 2003

Trends in incidence of and mortality from cancer in The Netherlands in the period 1989–1998

  • S. Siesling

      Affiliations

    • Head of the Department of Research and Registration, Comprehensive Cancer Centre Stedendriehoek Twente, Lasondersingel 133, 7514 BP Enschede, The Netherlands
    • Corresponding Author InformationCorresponding author. Tel.: +31-53-430-5010; fax: +31-53-430-6295
    • ,
  • J.A.A.M. van Dijck

      Affiliations

    • Comprehensive Cancer Centre East, Nijmegen, The Netherlands
    • Department of Epidemiology, University of Nijmegen, Nijmegen, The Netherlands
    • ,
  • O. Visser

      Affiliations

    • Comprehensive Cancer Centre Amsterdam, Amsterdam, The Netherlands
    • ,
  • J.W.W. Coebergh

      Affiliations

    • Comprehensive Cancer Centre South, Eindhoven, The Netherlands
    • Department of Public Health, Erasmus MC Rotterdam, Rotterdam, The Netherlands
    • ,
  • on behalf of the Working Group of The Netherlands Cancer Registry

Received 28 April 2003 ,Accepted 29 April 2003.

References 

  1. van der Sanden GA, Coebergh JW, Schouten LJ, Visser O, van Leeuwen FE. Cancer incidence in The Netherlands in 1989 and 1990 (first results of the nationwide Netherlands cancer registry. Coordinating Committee for Regional Cancer Registries). Eur. J. Cancer. 1995;31A:1822–1829
  2. Netherlands Central Bureau of Statistics. Atlas of Cancer Mortality in The Netherlands 1979–1990. SDU-CBS Publications, The Hague, 1992
  3. Vries de E., Schouten LJ, Visser O, Eggermont A.M.M, Coebergh J.W.W. Rising trends in incidence of and mortality from cutaneaous melanoma in the Netherlands since 1950: northwest to southeast gradient? Eur J Cancer 2003, 39, 1439–1446.
  4. Visser O, Coebergh JWW, Dijck van JAAM, Siesling S. Incidence of Cancer in The Netherlands 1998. Utrecht: Vereniging van Integrale Kankercentra; 2002;
  5. International Classification of Diseases for Oncology, 3rd edn. WHO, Geneva, 1976
  6. Hermanek P, Sobin LH. TNM Classification of Malignant Tumours. UICC International Union against Cancer. Berlin: Springer-Verlag; 1987;
  7. Schouten LJ, Jager JJ, van den Brandt PA. Quality of cancer registry data (a comparison of data provided by clinicians with those of registration personnel). Br. J. Cancer. 1993;68:974–977
  8. Schouten LJ, Hoppener P, van den Brandt PA, Knottnerus JA, Jager JJ. Completeness of cancer registration in Limburg, The Netherlands. Int. J. Epidemiol. 1993;22:369–376
  9. Kleinbaum DG, Kopper LL, Maller KE. Applied Regression Analysis and Other Multivariable Methods Boston, PWS-KENT, 1988.
  10. Janssen-Heijnen ML, Nab HW, van Reek J, van der Heijden LH, Schipper R, Coebergh JW. Striking changes in smoking behaviour and lung cancer incidence by histological type in south-east Netherlands, 1960–1991. Eur. J. Cancer. 1995;31A:949–952
  11. Janssen-Heijnen ML, Coebergh JW, Klinkhamer PJ, Schipper RM, Splinter TA, Mooi WJ. Is there a common etiology for the rising incidence of and decreasing survival with adenocarcinoma of the lung?. Epidemiology. 2001;12:256–258
  12. Boyle P, d'Onofrio A, Maisonneuve P, Serveri G, Robertson C, Tubiana M, et al. Measuring progress against cancer in Europe: has the 15% decline targeted for 2000 come about?. Ann Oncol. 2003;14:1312–1325
  13. Brennan P, Bray I. Recent trends and future directions for lung cancer mortality in Europe. Br. J. Cancer. 2002;87:43–48
  14. Crocetti E, Paci E. Trends in lung adenocarcinoma incidence and survival. Lung Cancer. 2002;35:215–216
  15. Janssen-Heijnen ML, Coebergh JW. Trends in incidence and prognosis of the histological subtypes of lung cancer in North America, Australia, New Zealand and Europe. Lung Cancer. 2001;31:123–137
  16. Levi F, Randimbison L, La Vecchia C, Erler G, Te VC. Multiple primary cancers to indicate associations between smoking and cancer incidence (Vaud and Neuchatel, Switzerland, 1974-1994). Int. J. Cancer. 1998;76:913–914
  17. Borras J, Borras JM, Galceran J, Sanchez V, Moreno V, Gonzalez JR. Trends in smoking-related cancer incidence in Tarragona, Spain, 1980–1996. Cancer Causes Control. 2001;12:903–908
  18. Laheij RJH, Straatman H, Verbeek ALM. Mortality trend from cancer of the gastric cardia in the Netherlands, 1969–1994. Int. J. Epidemiol. 1999;28:391–395
  19. Hayne D, Brown RS, McCormack M, Quinn MJ, Payne HA, Babb P. Current trends in colorectal cancer (site, incidence, mortality and survival in England and Wales). Clin. Oncol. (R. Coll. Radiol.). 2001;13:448–452
  20. Faivre-Finn C, Bouvier-Benhamiche AM, Phelip JM, Manfredi S, Dancourt V, Faivre J. Colon cancer in France (evidence for improvement in management and survival). Gut. 2002;51:60–64
  21. Manfredi S, Benhamiche AM, Isambert N, Prost P, Jouve JL, Faivre J. Trends in incidence and management of gallbladder carcinoma (a population-based study in France). Cancer. 2000;89:757–762
  22. Benhamiche AM, Faivre C, Minello A, et al.  Time trends and age-period-cohort effects on the incidence of primary liver cancer in a well-defined French population (1976–1995). J. Hepatol. 1998;29:802–806
  23. Kiemeney LA, Verbeek AL, Nelemans PJ, Witjes JA, Straatman H. Bladder cancer mortality in The Netherlands, 1955–1988. Br. J. Urol. 1992;70:46–52
  24. Bossetti C, Negri E, Trichopoulos D, et al.  Long-term effects of oral contraceptives on ovarian cancer risk. Int. J. Cancer. 2002;102:262–265
  25. La Vecchia C, Levi F, Lucchini F, Negri E, Franceschi S. Descriptive epidemiology of ovarian cancer in Europe. Gynecol. Oncol. 1992;46:208–215
  26. Cartwright RJ, Brincker H, Carli PM, Coebergh JWW, Morgan G. The rise in incidence of lymphomas in Europe, 1985–1992. Eur. J. Cancer. 1999;35:627–633
  27. Coebergh JW, Janssen ML, Louwman M, Voogd AC. Cancer, Incidence, Care and Survival in the South of The Netherlands, 1955–1999; A Report of the Eindhoven Cancer Registry with Cross-border Implications. Eindhoven: Comprehensive Cancer Centre South (IKZ); 2001;
  28. van Spronsen DJ, Dijkema IM, Vrints LW, et al.  Improved survival of Hodgkin's Patients in South-Netherlands since 1972. Eur. J. Cancer. 1997;33:436–441
  29. Levi F, Lucchini F, Negri E, Boyle P, La Vecchia C. Trends in mortality from Hodgkin's disease in western and eastern Europe. Br. J. Cancer. 2002;87:291–293
  30. Fracheboud J, Otto SJ, Groenewoud JH, et al. Landelijke evaluatie van bevolkingsonderzoek naar borstkanker in Nederland. Rotterdam, National Evaluation Team for Breast Cancer.
  31. van Dijck JA, Hendriks JH, Holland R, Schouten LJ, Verbeek AL. [Alterations of stage distribution for breast cancer since the implementation of national screening program in the Netherlands during 1989–1995]. Ned. Tijdschr. Geneeskd. 2000;144:1119–1124
  32. Levi F, Lucchini F, Negri E, La Vecchia C. Cancer mortality in the European Union, 1988–1997 (the fall may approach 80,000 deaths a year). Int. J. Cancer. 2002;98:636–637
  33. Silva ID, Swerdlow AJ. Recent trends in incidence of and mortality from breast, ovarian and endometrial cancers in England and Wales and their relation to changing fertility and oral contraceptive use. Br. J. Cancer. 1995;72:485–492
  34. Blanks RG, Moss SM, McGahan CE, Quinn MJ, Babb PJ. Effect of NHS breast screening programme on mortality from breast cancer in England and Wales, 1990–8 (comparison of observed with predicted mortality). Br. Med. J. 2000;321:665–669
  35. van der Graaf Y, Zielhuis GA, Vooijs GP. Cervical cancer mortality in the Netherlands. Int. J. Epidemiol. 1988;17:270–276
  36. van Ballegooijen M, Hermens R. Cervical cancer screening in the Netherlands. Eur. J. Cancer. 2000;36:2224–2226
  37. Hemminki K, Li X, Mutanen P. Age-incidence relationships and time trends in cervical cancer in Sweden. Eur. J. Epidemiol. 2001;17:323–328
  38. Hemminki K, Li X, Vaittinen P. Time trends in the incidence of cervical and other genital squamous cell carcinomas and adenocarcinomas in Sweden, 1958–1996. Eur. J. Obstet. Gynecol. Reprod. Biol. 2002;101:64–69
  39. Levi F, Lucchini F, Negri E, Franceschi S, La Vecchia C. Cervical cancer mortality in young women in Europe (patterns and trends). Eur. J. Cancer. 2000;36:2266–2271
  40. Giard RWM, Coebergh JWW, Casparie-van Velzen IJAMG. Sterke stijging van de detectiefrequentie van prostaatkanker in Nederland gedurende de periode 1990–1996. Ned. Tijdschr. Geneeskd. 1998;142:1958–1962
  41. Quinn M, Babb P. Patterns and trends in prostate cancer incidence, survival, prevalence and mortality. Part II (individual countries). BJU Int. 2002;90:174–184
  42. Quaglia A, Parodi S, Grosclaude P, Martinez-Garcia C, Coebergh JW, Vercelli M. Differences in the epidemic rise and decrease of prostate cancer among geographical areas in Southern Europe. an analysis of differential trends in incidence and mortality in France, Italy and Spain. Eur. J. Cancer. 2003;39:654–665
  43. Post PN, Straatman H, Kiemeney LA, Coebergh JWW. Increased risk of fatal prostate cancer may explain the risk in mortality in the Netherlands. Int. J. Epidemiol. 1999;28:403–408
  44. Dijck van JAAM, Coebergh JWW, Siesling S, Visser O. Trends in Cancer Incidence and Mortality in The Netherlands 1989–1998. Utrecht: Vereniging van Integrale Kankercentra; 2002;

PII: S0959-8049(03)00622-1

doi: 10.1016/S0959-8049(03)00622-1

European Journal of Cancer
Volume 39, Issue 17 , Pages 2521-2530 , November 2003

Article Tools

* Image Usage & Resolution